Project Grant R00ES034507
Award Date
9/1/24
Completion Date
8/31/27
Dollars Obligated
$550K
Funding Federal Agency
Office of the Director
Awarding Federal Agency
National Institute of Environmental Health Sciences
Federal Grant Program
93.077
Assistance Type
Project Grant
Place of Performance
Pennsylvania, USA
Similar Awards
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to investigate the impact of e-cigarette use on pulmonary gas exchange capacity in young adults using hyperpolarized xenon-129 MRI (HXeMRI) as a novel imaging biomarker. The total award is $3,002,492 with a performance period from Jul 15, 2024 to Apr 30, 2029. The key products and services to be delivered include: 1) Determining the impact of...
This $3,230,000 Project Grant was awarded by the National Institutes of Health (NIH) Office of the Director under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077). The grant supports research to investigate the cardiovascular health effects of dual use of smoking and e-cigarettes compared to exclusive use of either product. The research will be conducted at multiple levels, including studies in human participants and animal models, as well as...
This federal Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) will support research to identify and address misperceptions about the relative risks of e-cigarettes compared to traditional cigarettes. The $171,742 award to Rutgers, The State University of New Jersey aims to: 1) identify common belief patterns about cigarette and e-cigarette harms, 2) develop...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $187,500.00 to North Carolina Central University (NCCU) to assess the immunosuppressive effects of e-cigarette (e-cig) usage and its impact on susceptibility to pulmonary infections. The key objectives are to: 1) model lung cell immune dysfunction using human bronchial epithelial cells, 2) assess immune cell involvement and lung...
This $1,257,395 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI)'s Cardiovascular Diseases Research program (CFDA 93.837) aims to quantify the long-term effects of e-cigarette use on cardiovascular and pulmonary health. The study will recruit 400 long-term e-cigarette users and 200 non-users to undergo comprehensive biomarker assessments over 36 months, including measures of cardiovascular health, lung function, and nicotine dependence. The primary objectives are to...
The National Institutes of Health (NIH), through the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077), awarded a $669,321 project grant to the Regents of the University of California at Riverside (UC Riverside). The grant supports a 1-year study to characterize new and emerging ingredients, acids, toxicants, and indicators of non-tobacco nicotine in electronic cigarette (e-cigarette) products. The research will involve: Analyzing 600 commercial...
This $619,477 federal Project Grant awarded by the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health (CFDA 93.113) program supports research to investigate the impact of electronic cigarette (e-cigarette) exposure, both direct and in-utero, on vascular function and cognitive decline. The research, conducted by the West Virginia University Research Corporation, aims to establish the dose-dependent effects of e-cigarette exposure on vascular dysfunction and...
This $1,197,896 Project Grant was awarded on May 1, 2025 by the National Institutes of Health (NIH) Office of the Director under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077). The grant funds a 5-year longitudinal study to assess the impact of electronic nicotine delivery system (ENDS) product characteristics on use behaviors and abuse liability among young adult ENDS users (ages 18-25). The study employs traditional survey methods combined...
This federal Project Grant award, with a total funding amount of $230,618.00, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award supports research to investigate the mechanisms by which vaping a vitamin E acetate compound (A-T-acetate) generates a novel toxic compound that induces fever and lung inflammation, which has been linked to recent cases of e-cigarette or vaping...
This Project Grant award of $622,957 from the National Institutes of Health (NIH) Office of the Director, under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077), supports research by Duke University to investigate the chemical composition and behavioral effects of novel tobacco products, including oral nicotine pouches and "non-menthol" cigarettes. The study aims to analyze the flavors, sweeteners, and nicotine forms in these products, and...